To clarify the prognostic significance of CHRM3 in GBM, survival analysis was performed in TCGA database, which revealed that higher levels of CHRM3 were significantly related to poor survival in GBM patients (Fig. 1D). This evidence concerns the gene CHRM3 and glioblastoma.